These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25351105)

  • 1. The immune microenvironment in cutaneous leishmaniasis.
    Jabbour MN; Issa G; Charafeddine K; Simaan Y; Karam M; Khalifeh H; Habib R; Khalifeh I
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1170-9. PubMed ID: 25351105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and immunohistochemical clues for the diagnosis of cutaneous leishmaniasis and the interpretation of CD1a status.
    Fernandez-Flores A; Rodriguez-Peralto JL
    J Am Acad Dermatol; 2016 Mar; 74(3):536-43. PubMed ID: 26577511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic usefulness of immunohistochemical evaluation of CD1a antigen and polyclonal anti-leishmania antibodies in cutaneous leishmaniasis.
    Lopez-Trujillo E; Gonzàlez-Farré M; Pujol RM; Bellosillo B; Fisa R; Riera C; Alcover M; Barranco C; Martin-Ezquerra G
    Histol Histopathol; 2021 May; 36(5):567-576. PubMed ID: 33665791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic features of cutaneous leishmaniasis and use of CD1a staining for amastigotes in Old World and New World leishmaniasis.
    Sundharkrishnan L; North JP
    J Cutan Pathol; 2017 Dec; 44(12):1005-1011. PubMed ID: 28892183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation.
    Iliadis A; Koletsa T; Patsatsi A; Georgiou E; Sotiriadis D; Kostopoulos I
    Eur J Dermatol; 2016 Dec; 26(6):566-571. PubMed ID: 27545221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transepidermal elimination in cutaneous leishmaniasis: a multiregional study.
    Karram S; Loya A; Hamam H; Habib RH; Khalifeh I
    J Cutan Pathol; 2012 Apr; 39(4):406-12. PubMed ID: 22443392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts.
    Angel CE; Lala A; Chen CJ; Edgar SG; Ostrovsky LL; Dunbar PR
    Int Immunol; 2007 Nov; 19(11):1271-9. PubMed ID: 17804688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative study of epidermal Langerhans cells in cutaneous leishmaniasis caused by Leishmania tropica.
    Meymandi S; Dabiri S; Dabiri D; Crawford RI; Kharazmi A
    Int J Dermatol; 2004 Nov; 43(11):819-23. PubMed ID: 15533064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
    Sengupta R; Mukherjee S; Moulik S; Mitra S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():166-176. PubMed ID: 31542359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus.
    Bayer-Garner IB; Ivan D; Schwartz MR; Tschen JA
    Clin Med Res; 2004 May; 2(2):89-97. PubMed ID: 15931341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote.
    Locksley RM; Heinzel FP; Fankhauser JE; Nelson CS; Sadick MD
    Infect Immun; 1988 Feb; 56(2):336-42. PubMed ID: 2828237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD1a and CD86 on scleroderma Langerhans cells.
    Xie Y; Zhang X; Inoue Y; Wakasugi S; Makino T; Ihn H
    Eur J Dermatol; 2008; 18(1):50-4. PubMed ID: 18086589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathology of American tegumentary leishmaniasis].
    Castés M; Tapia FJ
    Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease.
    Deguchi M; Aiba S; Ohtani H; Nagura H; Tagami H
    Arch Dermatol Res; 2002 Oct; 294(7):297-302. PubMed ID: 12373334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double immunostaining with CD1A and CD68 in the phenotypic characterization of indeterminate cell histiocytosis.
    Fernandez-Flores A; Manjon JA; Manzarbeitia F
    Cesk Patol; 2008 Apr; 44(2):37-9. PubMed ID: 18819325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunophenotyping of exfoliative dermatitis in canine leishmaniosis (Leishmania infantum).
    Papadogiannakis EI; Koutinas AF; Saridomichelakis MN; Vlemmas J; Lekkas S; Karameris A; Fytianou A
    Vet Immunol Immunopathol; 2005 Apr; 104(3-4):227-37. PubMed ID: 15734543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.